Growth in prevalence of cancer is one of the key factors propelling the global single-cell analysis market size. Single-cell analysis entails sequencing of the entire human genome at a single cell level to measure as well as analyze cellular heterogeneity.
Extensive research activities are being undertaken regarding individual cell analysis to enable early detection and precise medication of chronic diseases.Companies functioning in the global single-cell analysis market are exploring the incorporation of advanced fiber optics into microfluidic chips on direct basis.
Leading market players are also striving to adopt optimization methods to map individual cells from single-cell RNA sequencing atlas to enable thorough single-cell characterization. Introduction of next-gen cellular heterogeneity study and cell-by-cell examination is one of the recent single-cell analysis industry trends.
Single-cell analysis devices, also called single-cell profiling devices, are used to comprehend central dogma of the molecular biology. Demand for single-cell analysis is rising in multi-omics based activities in drug R&D such as genomics, transcriptomics, proteomics, and metabolomics.
Individual cell analysis is a key to master advancements in drug discovery and disease diagnosis due to efficient cell sorting and tagging, high throughput assays, microfluidics, single-cell amplification, and sequencing facilitated by advanced technology.
Applications of single-cell genomics include single nucleotide polymorphism (SNP), gametogenesis, genetics, tumor evolution, somatic mosaicism, clinical diagnostics, and forensic analysis. Some of the single-cell data analysis tools include Cellenics, BioTuring Browser, 10x Loupe Browser, Partek Flow, Cellxgene, and ROSALIND.
High variability of data generated due to visualization of diverse gene expressions varying in cell stages and types is one of the key factors that is adversely affecting single-cell analysis market opportunities.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Single-cell RNA sequencing techniques with respect to cancer research are meant to analyze complex tissues at the single-cell levels that can identify differential gene expression and monitor progression of tumor development, thereby averting further cellular decline.
Single-cell proteomic analysis of the circulating tumor cells gives critical protein-level data, which, in turn, offers information about tumor issue’s malignancy and activation of signaling pathways, thereby allowing for accurate treatment planning.
Emerging single-cell sequencing technologies include cDNA library preparation and analytical algorithms.
As per World Cancer Research Fund International, nearly 18.1 million cases of cancer were prevalent across the globe in 2020. Furthermore, the WHO states that cancer accounted for almost 10 million fatalities in 2020. It also states that the common cancers are prostate, rectum, colon, and lung.
Substantial increase in the number of patients afflicted with cancer is driving the single-cell analysis market growth.
Early detection of chronic ailments and increase in awareness about the importance of precision medicine have resulted in extensive research in single-cell analysis. In January 2022, Amgen partnered with Generate Biomedicines to discover as well as create protein therapeutics for multiple modalities with initial investment of US$ 1.9 Bn.
In December 2021, Canopy Biosciences, a Bruker company, introduced assay kits for ChipCytometry. These kits are used for quantitatively imaging hordes of targeted protein biomarkers concurrently on single tissue section at single-cell spatial resolution to streamline user experience regarding ChipCytometry. According to clinicaltrials.gov, as of March 2021, there were almost 23,358 ongoing clinical trials in the field of oncology.
As per an article published in the Journal of Immunology Research (2020), single-cell RNA sequencing as well as analysis helps in the study of immune response to several infections. This, in turn, facilitates the development of effective vaccines targeted against causal organisms.
In March 2022, Biognosys introduced an expanded suite of proteomics platforms to provide deep biological insights, right from early-stage discovery to clinical settings. Abecma was the first cell-based gene therapy that was approved by the U.S. FDA to treat multiple myeloma. Thus, increase in R&D activities regarding cancer research is augmenting the single-cell analysis market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the recent single-cell analysis market analysis, North America accounted for the largest share of the global landscape in 2023. The region is projected to maintain its dominance during the forecast period. Rise in prevalence of cancer and advancements in single-cell omics technologies are propelling the market statistics of North America.
The single-cell analysis market share of Asia Pacific has been increasing at a rapid pace since the last few years owing to the growth in number of cancer patients in the region. Significant improvement in healthcare infrastructure is also fostering market expansion in the region.
Companies operating in the global single-cell analysis landscape are focusing on new product launch to establish a strong foothold in the highly competitive industry. For instance, in February 2021, SeqWell Inc. announced that it had launched PlexWell Single Cell Rapid Kit that can be used for preparing NGS libraries and single-cell RNA sequencing.
Leading players are also concentrating on inorganic growth to expand their global footprint. For instance, in February 2021, SeqWell Inc. collaborated with CELLINK AB to commercialize its products to increase its reach outside the U.S.
Thermo Fisher Scientific, WaferGen Bio-systems, Becton, Dickinson and Company, Standard BioTools Inc., Eppendorf, QIAGEN N.V., NewGEN Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and 10x Genomics are the leading players covered in the single-cell analysis market report.
These companies have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 3.4 Bn |
| Market Forecast (Value) in 2034 | US$ 14.8 Bn |
| Growth Rate (CAGR) | 13.9% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 3.4 Bn in 2023
It is projected to advance at a CAGR of 13.9% from 2024 to 2034
Growth in incidence of cancer and surge in R&D activities
The hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Thermo Fisher Scientific, WaferGen Bio-systems, Becton, Dickinson and Company, Standard BioTools Inc., Eppendorf, QIAGEN N.V., NewGEN Technologies, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., and 10x Genomics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Single-cell Analysis Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Single-cell Analysis Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Single-cell Analysis Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2020-2034
6.3.1. Instruments
6.3.1.1. Cell Counters
6.3.1.2. Spectrophotometers
6.3.1.3. Sequencers
6.3.1.4. Imaging Systems
6.3.1.5. Cytometers
6.3.1.6. PCR
6.3.1.7. Others
6.3.2. Consumables
6.3.2.1. Reagents & Kits
6.3.2.2. Micropipettes & Microplates
6.3.2.3. Others
6.4. Market Attractiveness Analysis, by Product
7. Global Single-cell Analysis Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2020-2034
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Biotechnology & Biopharmaceutical Companies
7.3.4. Research Laboratories
7.3.5. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Single-cell Analysis Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2020-2034
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Single-cell Analysis Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Product, 2020-2034
9.3.1. Instruments
9.3.1.1. Cell Counters
9.3.1.2. Spectrophotometers
9.3.1.3. Sequencers
9.3.1.4. Imaging Systems
9.3.1.5. Cytometers
9.3.1.6. PCR
9.3.1.7. Others
9.3.2. Consumables
9.3.2.1. Reagents & Kits
9.3.2.2. Micropipettes & Microplates
9.3.2.3. Others
9.4. Market Value Forecast, by End-user, 2020-2034
9.4.1. Hospitals
9.4.2. Diagnostic Centers
9.4.3. Biotechnology & Biopharmaceutical Companies
9.4.4. Research Laboratories
9.4.5. Others
9.5. Market Value Forecast, by Country, 2020-2034
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By End-user
9.6.3. By Country
10. Europe Single-cell Analysis Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product, 2020-2034
10.3.1. Instruments
10.3.1.1. Cell Counters
10.3.1.2. Spectrophotometers
10.3.1.3. Sequencers
10.3.1.4. Imaging Systems
10.3.1.5. Cytometers
10.3.1.6. PCR
10.3.1.7. Others
10.3.2. Consumables
10.3.2.1. Reagents & Kits
10.3.2.2. Micropipettes & Microplates
10.3.2.3. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Diagnostic Centers
10.4.3. Biotechnology & Biopharmaceutical Companies
10.4.4. Research Laboratories
10.4.5. Others
10.5. Market Value Forecast, by Country/Sub-region, 2020-2034
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By End-user
10.6.3. By Country/Sub-region
11. Asia Pacific Single-cell Analysis Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product, 2020-2034
11.3.1. Instruments
11.3.1.1. Cell Counters
11.3.1.2. Spectrophotometers
11.3.1.3. Sequencers
11.3.1.4. Imaging Systems
11.3.1.5. Cytometers
11.3.1.6. PCR
11.3.1.7. Others
11.3.2. Consumables
11.3.2.1. Reagents & Kits
11.3.2.2. Micropipettes & Microplates
11.3.2.3. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Diagnostic Centers
11.4.3. Biotechnology & Biopharmaceutical Companies
11.4.4. Research Laboratories
11.4.5. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By End-user
11.6.3. By Country/Sub-region
12. Latin America Single-cell Analysis Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product, 2020-2034
12.3.1. Instruments
12.3.1.1. Cell Counters
12.3.1.2. Spectrophotometers
12.3.1.3. Sequencers
12.3.1.4. Imaging Systems
12.3.1.5. Cytometers
12.3.1.6. PCR
12.3.1.7. Others
12.3.2. Consumables
12.3.2.1. Reagents & Kits
12.3.2.2. Micropipettes & Microplates
12.3.2.3. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Diagnostic Centers
12.4.3. Biotechnology & Biopharmaceutical Companies
12.4.4. Research Laboratories
12.4.5. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By End-user
12.6.3. By Country/Sub-region
13. Middle East & Africa Single-cell Analysis Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product, 2020-2034
13.3.1. Instruments
13.3.1.1. Cell Counters
13.3.1.2. Spectrophotometers
13.3.1.3. Sequencers
13.3.1.4. Imaging Systems
13.3.1.5. Cytometers
13.3.1.6. PCR
13.3.1.7. Others
13.3.2. Consumables
13.3.2.1. Reagents & Kits
13.3.2.2. Micropipettes & Microplates
13.3.2.3. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Diagnostic Centers
13.4.3. Biotechnology & Biopharmaceutical Companies
13.4.4. Research Laboratories
13.4.5. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By End-user
13.6.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2023)
14.3. Company Profiles
14.3.1. Thermo Fisher Scientific
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. WaferGen Bio-systems
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview
14.3.3. Becton, Dickinson and Company
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Standard BioTools Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Eppendorf
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. QIAGEN N.V.
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. NewGEN Technologies, Inc.
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Bio-Rad Laboratories, Inc.
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Illumina, Inc.
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview
14.3.10. 10x Genomics
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
List of Tables
Table 01: Global Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 02: Global Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 03: Global Single-cell Analysis Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 04: North America Single-cell Analysis Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 05: North America Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 06: North America Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 07: Europe Single-cell Analysis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 08: Europe Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 09: Europe Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 10: Asia Pacific Single-cell Analysis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 11: Asia Pacific Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 12: Asia Pacific Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Latin America Single-cell Analysis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Latin America Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 15: Latin America Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 16: Middle East & Africa Single-cell Analysis Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 17: Middle East & Africa Single-cell Analysis Market Size (US$ Mn) Forecast, by Product, 2020-2034
Table 18: Middle East & Africa Single-cell Analysis Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Single-cell Analysis Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Single-cell Analysis Market Revenue (US$ Mn), by Product, 2023
Figure 03: Global Single-cell Analysis Market Value Share, by Product, 2023
Figure 04: Global Single-cell Analysis Market Revenue (US$ Mn), by End-user, 2023
Figure 05: Global Single-cell Analysis Market Value Share, by End-user, 2023
Figure 06: Global Single-cell Analysis Market Value Share, by Region, 2023
Figure 07: Global Single-cell Analysis Market Value (US$ Mn) Forecast, 2024-2034
Figure 08: Global Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 09: Global Single-cell Analysis Market Attractiveness Analysis, by Product, 2023-2034
Figure 10: Global Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 11: Global Single-cell Analysis Market Attractiveness Analysis, by End-user, 2023-2034
Figure 12: Global Single-cell Analysis Market Value Share Analysis, by Region, 2023 and 2034
Figure 13: Global Single-cell Analysis Market Attractiveness Analysis, by Region, 2023-2034
Figure 14: North America Single-cell Analysis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 15: North America Single-cell Analysis Market Attractiveness Analysis, by Country, 2024-2034
Figure 16: North America Single-cell Analysis Market Value Share Analysis, by Country, 2023 and 2034
Figure 17: North America Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 18: North America Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 19: North America Single-cell Analysis Market Attractiveness Analysis, by Product, 2024-2034
Figure 20: North America Single-cell Analysis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 21: Europe Single-cell Analysis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 22: Europe Single-cell Analysis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 23: Europe Single-cell Analysis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 24: Europe Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 25: Europe Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 26: Europe Single-cell Analysis Market Attractiveness Analysis, by Product, 2024-2034
Figure 27: Europe Single-cell Analysis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 28: Asia Pacific Single-cell Analysis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 29: Asia Pacific Single-cell Analysis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 30: Asia Pacific Single-cell Analysis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 31: Asia Pacific Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 32: Asia Pacific Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Asia Pacific Single-cell Analysis Market Attractiveness Analysis, by Product, 2024-2034
Figure 34: Asia Pacific Single-cell Analysis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 35: Latin America Single-cell Analysis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 36: Latin America Single-cell Analysis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 37: Latin America Single-cell Analysis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 38: Latin America Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 39: Latin America Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 40: Latin America Single-cell Analysis Market Attractiveness Analysis, by Product, 2024-2034
Figure 41: Latin America Single-cell Analysis Market Attractiveness Analysis, by End-user, 2024-2034
Figure 42: Middle East & Africa Single-cell Analysis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 43: Middle East & Africa Single-cell Analysis Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 44: Middle East & Africa Single-cell Analysis Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 45: Middle East & Africa Single-cell Analysis Market Value Share Analysis, by Product, 2023 and 2034
Figure 46: Middle East & Africa Single-cell Analysis Market Value Share Analysis, by End-user, 2023 and 2034
Figure 47: Middle East & Africa Single-cell Analysis Market Attractiveness Analysis, by Product, 2024-2034
Figure 48: Middle East & Africa Single-cell Analysis Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Single-Cell Analysis Market
*86 figures and 60 tables includes